Dr Lal Pathlabs' stock slips ~4% owing to frail Q3FY22 numbers

11 Feb 2022 , 11:41 AM

Dr. Lal Pathlabs’ stock was trading in the lower as the company reported weak numbers for the quarter and nine months ended December 2021. Its share was trading at Rs2,814, down by Rs114.20 or 3.90% against its previous closing price of Rs2,928.20. It touched the day’s low of Rs2,814 so far in today’s trade.

The company posted a net profit of Rs58.20 crore in the quarter ended December 2021 as against Rs95.90 crore for the previous corresponding quarter. Its total revenue for the current quarter witnessed single-digit growth of 9.8% yoy at Rs497 crore against Rs452.40 crore for the same quarter last year.

Its EBITDA witnessed a decline of 21.3% yoy at Rs109 crore in Q3FY22 against Rs139 crore in Q3FY21.

Moreover, the EBITDA margin narrowed to 22% for the quarter ended December 2021 as compared to 30.7% in the previous corresponding quarter.

Normalized EBITDA (adjusted) for the third quarter reported at Rs141.80 crore as compared to Rs144.60 crore in the previous corresponding quarter.

The company’s PBT reported at Rs81.5 crore in October-December as against Rs128.9 crore the same period a year ago, shedding 36.78% yoy.